← Back to headlines
Argenx Acquires Forte Biosciences for $2.2 Billion
Argenx has signed an agreement to acquire Forte Biosciences in a deal valued at $2.2 billion.
28 Jul, 09:35 — 28 Jul, 09:35
Sources
Showing 1 of 1 sources
Related Stories
Trump Dispatches Envoys Witkoff and Kushner to Negotiate Ukraine Peace Deal
25m ago
Trump Threatens Iran Nuclear Site, Asserts Putin Will Not Attack NATO
30m ago
Israeli Airstrikes Kill Three in Southern Lebanon
42m ago
FBI Adds German National to Most Wanted List Over Alleged $26 Million Fraud Scheme
1h ago